DEA Reclassifies Plant-Derived Marijuana Medicine to Schedule V
DEA Reclassifies Plant-Derived Marijuana Medicine to Schedule V | NORML Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), has been reclassified today by the US Drug…
